[1] [5] As of 2023, it is the first and currently only oral GLP-1 receptor agonist available, offering an alternative to injectable formulations
Never self-medicate without checking with your Physician
Compounded GLP-1s have not been evaluated by the FDA, but side effects are expected to be similar to other GLP-1-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
Under the Federal Food, Drug, and Cosmetic Act (FDCA), selling unapproved peptides for human consumption can violate statutes prohibiting the introduction of misbranded or adulterated drugs into interstate commerce (21 U.S.C